215 related articles for article (PubMed ID: 16022181)
1. Recent advances in positive allosteric modulators of metabotropic glutamate receptors.
Shipe WD; Wolkenberg SE; Williams DL; Lindsley CW
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):449-57. PubMed ID: 16022181
[TBL] [Abstract][Full Text] [Related]
2. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors.
Marino MJ; Conn PJ
Curr Opin Pharmacol; 2006 Feb; 6(1):98-102. PubMed ID: 16368268
[TBL] [Abstract][Full Text] [Related]
3. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.
Kew JN
Pharmacol Ther; 2004 Dec; 104(3):233-44. PubMed ID: 15556676
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptors for new treatments in schizophrenia.
Herman EJ; Bubser M; Conn PJ; Jones CK
Handb Exp Pharmacol; 2012; (213):297-365. PubMed ID: 23027420
[TBL] [Abstract][Full Text] [Related]
5. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
Kew JN; Kemp JA
Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
[TBL] [Abstract][Full Text] [Related]
6. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
Feng Z; Ma S; Hu G; Xie XQ
AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Chronic Pain by Metabotropic Glutamate Receptors.
Chiechio S
Adv Pharmacol; 2016; 75():63-89. PubMed ID: 26920009
[TBL] [Abstract][Full Text] [Related]
8. Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia.
Fraley ME
Expert Opin Ther Pat; 2009 Sep; 19(9):1259-75. PubMed ID: 19552508
[TBL] [Abstract][Full Text] [Related]
9. A novel class of positive allosteric modulators of metabotropic glutamate receptor subtype 1 interact with a site distinct from that of negative allosteric modulators.
Hemstapat K; de Paulis T; Chen Y; Brady AE; Grover VK; Alagille D; Tamagnan GD; Conn PJ
Mol Pharmacol; 2006 Aug; 70(2):616-26. PubMed ID: 16645124
[TBL] [Abstract][Full Text] [Related]
10. Nociception modulation by supraspinal group III metabotropic glutamate receptors.
Palazzo E; Marabese I; Luongo L; Guida F; de Novellis V; Maione S
J Neurochem; 2017 May; 141(4):507-519. PubMed ID: 27363363
[TBL] [Abstract][Full Text] [Related]
11. Isoxazolo[3,4-d]pyridazinones positively modulate the metabotropic glutamate subtypes 2 and 4.
Gates C; Backos DS; Reigan P; Kang HJ; Koerner C; Mirzaei J; Natale NR
Bioorg Med Chem; 2018 Sep; 26(17):4797-4803. PubMed ID: 30143366
[TBL] [Abstract][Full Text] [Related]
12. Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonist.
McCullock TW; Kammermeier PJ
Pharmacol Res Perspect; 2019 Jun; 7(3):e00471. PubMed ID: 31065376
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate receptors: physiology, pharmacology, and disease.
Niswender CM; Conn PJ
Annu Rev Pharmacol Toxicol; 2010; 50():295-322. PubMed ID: 20055706
[TBL] [Abstract][Full Text] [Related]
14. Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site.
Rowe BA; Schaffhauser H; Morales S; Lubbers LS; Bonnefous C; Kamenecka TM; McQuiston J; Daggett LP
J Pharmacol Exp Ther; 2008 Jul; 326(1):240-51. PubMed ID: 18430863
[TBL] [Abstract][Full Text] [Related]
15. Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
Chen Y; Nong Y; Goudet C; Hemstapat K; de Paulis T; Pin JP; Conn PJ
Mol Pharmacol; 2007 May; 71(5):1389-98. PubMed ID: 17303702
[TBL] [Abstract][Full Text] [Related]
16. A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors.
Hemstapat K; Da Costa H; Nong Y; Brady AE; Luo Q; Niswender CM; Tamagnan GD; Conn PJ
J Pharmacol Exp Ther; 2007 Jul; 322(1):254-64. PubMed ID: 17416742
[TBL] [Abstract][Full Text] [Related]
17. A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain.
O'Brien JA; Lemaire W; Wittmann M; Jacobson MA; Ha SN; Wisnoski DD; Lindsley CW; Schaffhauser HJ; Rowe B; Sur C; Duggan ME; Pettibone DJ; Conn PJ; Williams DL
J Pharmacol Exp Ther; 2004 May; 309(2):568-77. PubMed ID: 14747613
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate receptor ligands as potential therapeutics for addiction.
Olive MF
Curr Drug Abuse Rev; 2009 Jan; 2(1):83-98. PubMed ID: 19630739
[TBL] [Abstract][Full Text] [Related]
19. Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders.
Cleva RM; Olive MF
Molecules; 2011 Mar; 16(3):2097-106. PubMed ID: 21368721
[TBL] [Abstract][Full Text] [Related]
20. Role of metabotropic glutamate receptors in the control of neuroendocrine function.
Durand D; Pampillo M; Caruso C; Lasaga M
Neuropharmacology; 2008 Sep; 55(4):577-83. PubMed ID: 18616955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
